GlassScriptPhysician profile
Carey A Dellock
NPI 1003879131
$10,561.61
in general payments reported to CMS, 2019-2025
35 companies · $2,697 in 2025
The $2,697 reported for 2025 was more than what 87% of Cardiovascular Disease providers received nationally (typical 2025 total: $433).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $3,232 · 2020: $591 · 2021: $307 · 2022: $1,329 · 2023: $1,053 · 2024: $1,352 · 2025: $2,697.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $4,046 · Travel and Lodging: $1,056.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $4,046.23 |
| Travel and Lodging | $1,056.22 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Medtronic, INC. | $3,330.60 | 2021-2025 | Corevalve Evolut R, Symplicity G3, Linq II |
| Medtronic Vascular, INC. | $1,961.64 | 2019-2020 | |
| Boston Scientific Corporation | $821.97 | 2019-2025 | Avvigo Guidance System, Rotapro, Ffr Link |
| Abiomed | $743.70 | 2019-2025 | Impella |
| Penumbra, INC. | $703.31 | 2019-2025 | Indigo System |
| Shockwave Medical, INC | $569.72 | 2022-2025 | Shockwave Ivl System With The Shockwave C2 Coronary Ivl Catheter |
| Abbott Laboratories | $526.70 | 2019-2025 | Jot Dx, Confirm Rx, Gallant |
| Novartis Pharmaceuticals Corporation | $345.81 | 2019-2024 | |
| Cardiva Medical, INC. | $260.78 | 2024-2025 | Cardiva Vascade Mvp Vvcs 6-12f, Cardiva Vascade 6/7f Vcs, Optowire |
| Astrazeneca Pharmaceuticals LP | $198.00 | 2019-2020 | |
| E.R. Squibb & Sons, L.L.C. | $137.67 | 2020-2025 | Camzyos |
| Pfizer INC. | $127.38 | 2019-2023 | |
| Amgen INC. | $113.91 | 2019-2023 | Repatha |
| Zoll Services LLC (A/K/A Zoll Lifecor Corp) | $100.10 | 2019-2025 | Lifevest |
| Irhythm Technologies, INC. | $67.51 | 2022-2023 | Zio Xt Patch |
Show all 35 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Atricure, INC. | $61.78 | 2023-2025 | Atriclip Laa Exclusion System, Synergy Ablation System |
| Astellas Pharma US INC | $59.09 | 2019-2021 | |
| Janssen Pharmaceuticals, INC | $50.84 | 2019-2020 | |
| Merck Sharp & Dohme LLC | $44.43 | 2023-2025 | Verquvo, Capvaxive |
| Biosense Webster, INC. | $39.50 | 2025 | Na |
| Edwards Lifesciences Corporation | $38.74 | 2023 | Edwards Sapien 3 Ultra Transcatheter Heart Valve |
| Teleflex LLC | $33.22 | 2022-2023 | Manta |
| Philips North America LLC | $31.36 | 2023-2024 | (Cm9) Amb Mon & Diag Und |
| Kiniksa Pharmaceuticals International, Plc | $26.21 | 2024 | Arcalyst |
| Sanofi-Aventis U.S. LLC | $20.08 | 2019 | |
| Actelion Pharmaceuticals US, INC. | $17.69 | 2022 | |
| Vital Connect, INC | $17.64 | 2025 | Vitalpatch Rtm |
| Kiniksa Pharmaceuticals, LTD. | $16.73 | 2023 | Arcalyst |
| Kestra Medical Technology Services, INC. | $16.63 | 2025 | Assure Wcd |
| Inari Medical, INC. | $15.19 | 2021 | |
| Baxter Healthcare | $15.04 | 2023 | Hillrom - Carnation Ambulatory Monitor |
| Alexion Pharmaceuticals, INC. | $12.47 | 2021 | |
| Portola Pharmaceuticals, LLC | $12.21 | 2019 | |
| Bardy Diagnostics, INC. | $12.00 | 2021 | |
| Boehringer Ingelheim Pharmaceuticals, INC. | $11.96 | 2019 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Carey Dellock listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.